Cargando…
Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis‐related ovarian cancers
The ARID1A tumour suppressor protein is a component of the SWI/SNF chromatin remodelling complex, which is mutated in approximately 20% of all human cancers. ARID1A mutational status is considered to hold prognostic significance in a range of solid malignancies, yet in endometriosis‐related ovarian...
Autores principales: | Khalique, Saira, Nash, Sarah, Natrajan, Rachael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540905/ https://www.ncbi.nlm.nih.gov/pubmed/35647895 http://dx.doi.org/10.1002/path.5973 |
Ejemplares similares
-
Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers
por: Khalique, Saira, et al.
Publicado: (2018) -
Towards a more biologically informative system of endometriosis classification
por: Mijatovic, Velja
Publicado: (2020) -
Clarifying the Definition of Breast-Milk Substitutes
por: Grummer-Strawn, Laurence M.
Publicado: (2018) -
The definition of sexual selection: a response to comments on Shuker and Kvarnemo
por: Shuker, David M, et al.
Publicado: (2021) -
ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
por: Samartzis, Eleftherios P., et al.
Publicado: (2013)